{"entity":{"type":"insider","cik":"0001606243","url":"/insider/0001606243","json_url":"/insider/0001606243.json","name":"Rickey James Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2019-06-03","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Rickey James Paul","source":"filing","n_filings":9,"first_seen":"2019-06-03","last_seen":"2026-08-07"}],"transactions":[{"id":6129788,"accession":"0001470831-26-000804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000804","line_url":"/filing/0001470831-26-000804#line-1","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"Braveheart Bio, Inc.","issuer_ticker":"BRVE","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27777.0,"shares_display":"27,777","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":499986.0,"total_display":"499,986.00","shares_owned_after":520927.0,"shares_owned_after_display":"520,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-07","scope":"insider"},{"id":3095796,"accession":"0001626199-24-000027","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001626199-24-000027","line_url":"/filing/0001626199-24-000027#line-6","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73764.0,"shares_display":"73,764","price_per_share":22.3121,"price_display":"22.31","price_state":"stated","total_value":1645829.7444,"total_display":"1,645,829.74","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-29","scope":"insider"},{"id":3095791,"accession":"0001626199-24-000027","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001626199-24-000027","line_url":"/filing/0001626199-24-000027#line-5","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44000.0,"shares_display":"44,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":1100000.0,"total_display":"1,100,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-29","scope":"insider"},{"id":3095776,"accession":"0001626199-24-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626199-24-000027","line_url":"/filing/0001626199-24-000027#line-2","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236.0,"shares_display":"236","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":5192.0,"total_display":"5,192.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":8025005,"accession":"0001626199-23-000145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626199-23-000145","line_url":"/filing/0001626199-23-000145#line-2","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15213.0,"shares_display":"15,213","price_per_share":19.2087,"price_display":"19.21","price_state":"stated","total_value":292221.9531,"total_display":"292,221.95","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-21","scope":"insider"},{"id":8024891,"accession":"0001606243-23-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001606243-23-000006","line_url":"/filing/0001606243-23-000006#line-6","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":19.0017,"price_display":"19.00","price_state":"stated","total_value":34203.06,"total_display":"34,203.06","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-18","scope":"insider"},{"id":8024887,"accession":"0001606243-23-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001606243-23-000006","line_url":"/filing/0001606243-23-000006#line-4","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45387.0,"shares_display":"45,387","price_per_share":19.0888,"price_display":"19.09","price_state":"stated","total_value":866383.3656,"total_display":"866,383.37","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-18","scope":"insider"},{"id":8024884,"accession":"0001606243-23-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001606243-23-000006","line_url":"/filing/0001606243-23-000006#line-2","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11600.0,"shares_display":"11,600","price_per_share":19.0005,"price_display":"19.00","price_state":"stated","total_value":220405.8,"total_display":"220,405.80","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":8268036,"accession":"0001626199-23-000128","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001626199-23-000128","line_url":"/filing/0001626199-23-000128#line-6","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6446.0,"shares_display":"6,446","price_per_share":16.0797,"price_display":"16.08","price_state":"stated","total_value":103649.7462,"total_display":"103,649.75","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-06","scope":"insider"},{"id":8268030,"accession":"0001626199-23-000128","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001626199-23-000128","line_url":"/filing/0001626199-23-000128#line-4","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":418.0,"shares_display":"418","price_per_share":16.0139,"price_display":"16.01","price_state":"stated","total_value":6693.8102,"total_display":"6,693.81","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8268020,"accession":"0001626199-23-000128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626199-23-000128","line_url":"/filing/0001626199-23-000128#line-2","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63947.0,"shares_display":"63,947","price_per_share":16.0584,"price_display":"16.06","price_state":"stated","total_value":1026886.5048,"total_display":"1,026,886.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":8592861,"accession":"0001606243-23-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001606243-23-000003","line_url":"/filing/0001606243-23-000003#line-2","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":11200.0,"total_display":"11,200.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider"},{"id":8689945,"accession":"0001626199-23-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001626199-23-000119","line_url":"/filing/0001626199-23-000119#line-2","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18003.0,"shares_display":"18,003","price_per_share":16.0281,"price_display":"16.03","price_state":"stated","total_value":288553.8843,"total_display":"288,553.88","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-06","filed_date":"2023-11-08","scope":"insider"},{"id":6762840,"accession":"0001626199-22-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626199-22-000018","line_url":"/filing/0001626199-22-000018#line-1","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer (Senior VP and CFO)","officer_title":"Senior VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17013.0,"shares_display":"17,013","price_per_share":13.9162,"price_display":"13.92","price_state":"stated","total_value":236756.3106,"total_display":"236,756.31","shares_owned_after":7014.0,"shares_owned_after_display":"7,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-31","filed_date":"2022-01-04","scope":"insider"},{"id":8544088,"accession":"0000899243-19-015346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-015346","line_url":"/filing/0000899243-19-015346#line-1","is_derivative":false,"issuer_cik":"0001606243","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001606243","owner_cik":"0001606243","owner_name":"Rickey James Paul","owner_url":"/insider/0001606243","role":"Officer (Senior VP and CFO)","officer_title":"Senior VP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":49500.0,"total_display":"49,500.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002131524","name":"Braveheart Bio, Inc.","url":"/issuer/0002131524","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2026-08-07","last_seen":"2026-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Officer","n_filings":8,"first_seen":"2019-06-03","last_seen":"2024-01-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001606243","retrieved_at":"2026-08-21T12:35:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}